| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/16/1993 | WO1993015197A3 Expression of osteogenic factor op-1 in cells of spodoptera frugiperda infected with recombinant baculovirus |
| 09/16/1993 | CA2452130A1 Methods and compositions for targeting the vasculature of solid tumors |
| 09/16/1993 | CA2383007A1 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 09/16/1993 | CA2131995A1 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
| 09/16/1993 | CA2131898A1 Methods and compositions for the modulation of host immune response to allergens |
| 09/16/1993 | CA2131801A1 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa) |
| 09/16/1993 | CA2131692A1 An anti-idiotypic antibody and its use in diagnosis and therapy in hiv-related disease |
| 09/16/1993 | CA2131552A1 Neurotrophic factors having altered receptor binding specificities |
| 09/16/1993 | CA2131549A1 Compositions and methods for pace 4 and 4.1 gene and polypeptides in cells |
| 09/16/1993 | CA2131539A1 Assay for adrenal autoantigen |
| 09/16/1993 | CA2131524A1 Use of interleukin-10 to suppress graft-vs.-host disease |
| 09/16/1993 | CA2131444A1 Dna encoding taurine and gaba transporters and uses thereof |
| 09/16/1993 | CA2131389A1 Thrombin receptor antagonists |
| 09/16/1993 | CA2131369A1 Microorganisms having attenuated invasiveness |
| 09/16/1993 | CA2131367A1 New anticoagulant peptide derivatives and pharmaceutical compositions containing the same as well as a process for the preparation thereof |
| 09/16/1993 | CA2131305A1 Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules |
| 09/16/1993 | CA2131299A1 Lymphocyte activity regulation by hla peptides |
| 09/16/1993 | CA2131150A1 Receptor complexes with b29 (ig-beta or ig-gamma) and their uses |
| 09/16/1993 | CA2130359A1 Compositions and methods for modulating rna |
| 09/16/1993 | CA2130100A1 Receptor internalization signals |
| 09/16/1993 | CA2130089A1 Protein compound, coding nucleotide sequences, producing cell line and uses thereof |
| 09/16/1993 | CA2129514A1 Controlled released acth containing microspheres |
| 09/16/1993 | CA2102609A1 Phospholipase c-inhibiting peptides |
| 09/15/1993 | EP0560730A2 New derivatives of beta-amino acids with anti-thrombotic activity |
| 09/15/1993 | EP0560723A1 Method and composition for the treatment of osteoporosis |
| 09/15/1993 | EP0560274A1 Antiherpes peptide derivatives having a ureido N-terminus |
| 09/15/1993 | EP0560267A1 Isosteric antiherpes peptide derivatives |
| 09/15/1993 | EP0560156A2 Pseudorabies virus polynucleotids and their use in the production of virus-resistant eucaryotic cells |
| 09/15/1993 | EP0559895A1 Albumin preparation and preservation thereof |
| 09/15/1993 | EP0559856A1 Antimicrobial preservation of platelets and blood factors |
| 09/15/1993 | EP0559793A1 Hiv protease inhibitors |
| 09/15/1993 | EP0559769A1 Heparin binding mitogen with homology to epidermal growth factor (egf) |
| 09/15/1993 | EP0559751A1 Treatment for osteoporosis using growth hormone release factor (grf) in combination with parathyroid hormone (pth). |
| 09/15/1993 | EP0559647A1 Composition and treatment with biologically active peptides and antibiotics which inhibit dna gyrase |
| 09/15/1993 | EP0546013A4 Glucagon analogs with asp?9 replacements or deletions |
| 09/15/1993 | EP0509047B1 Method for inhibiting follicular maturation |
| 09/15/1993 | EP0458950B1 Stabilization of k2p pro |
| 09/15/1993 | EP0457837A4 Stabilization of aqueous-based hydrophobic protein solutions and sustained release vehicle |
| 09/15/1993 | EP0276278B1 Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| 09/15/1993 | CN1076200A New derivatives of beta-amino acids |
| 09/15/1993 | CN1076199A 新的肽衍生物 New peptide derivatives |
| 09/15/1993 | CN1076114A Process for preparing nerve growth factor |
| 09/15/1993 | CA2159661A1 Phenylalanine-glycine derivatives, process for preparation thereof, and pharmaceutical composition containing said derivatives |
| 09/15/1993 | CA2159660A1 Phenylalanine-glycine derivatives, process for preparation thereof, and pharmaceutical composition containing said derivatives |
| 09/15/1993 | CA2091316A1 Phenylalanine-glycine derivatives, process for preparation thereof, and pharmaceutical composition containing said derivatives |
| 09/14/1993 | US5245079 Processes and intermediates for N-(S-3-alkyl-heptanoyl)-D-gamma-glutamyl-glycyl-D-alanine |
| 09/14/1993 | US5245017 Method for isolating CEA-binding protein |
| 09/14/1993 | US5245015 Monoclonal antibodies which neutralize HIV-1 through reaction with a conformational epitope in vitro |
| 09/14/1993 | US5245014 Method for isolating factors viii from plasma by gel filtration chromatography under group separation conditions |
| 09/14/1993 | US5245013 Acute phase protein modulating endotoxic activity of lipopolysaccharides, assay methods and polypeptides |
| 09/14/1993 | US5245010 Polypeptide of herpes simplex virus vmw 65 protein |
| 09/14/1993 | US5245009 CRF antagonists |
| 09/14/1993 | US5244910 Renin inhibitors |
| 09/14/1993 | US5244889 Treatment of cardiovascular disorders |
| 09/14/1993 | US5244884 Tripeptide |
| 09/14/1993 | US5244883 Nonapeptide bombesin antagonists |
| 09/14/1993 | US5244882 Porcine growth hormone analogs, and compositions |
| 09/14/1993 | US5244807 Production of pseudomonas xa cells containing indolyl-3-alkane alpha-hydroxylase |
| 09/14/1993 | US5244801 Process for producing monoclonal antibodies which specifically bind to benign colonic adenomatous polyps of human origin and hybridomas and monoclonal antibodies produced by said process |
| 09/14/1993 | US5244793 TGF-β1/β2: a novel chimeric transforming growth factor-beta |
| 09/14/1993 | US5244676 Genetic engineering |
| 09/14/1993 | US5244673 Antiexudation, antiphlogistic and antimicrobial effect; aqueous or ointment base with protease inhibitor comprising elastatinal optionally mixed with aprotinin and/or soybean trypsin inhibitors |
| 09/14/1993 | US5244671 Derivatives of porphycene for photodynamic therapy of cancer |
| 09/14/1993 | US5244666 Presurgical skin scrub and disinfectant |
| 09/14/1993 | US5244655 Three chromatographic stages using, as stationary phases, glass particles of controlled porosity, cation exchange resins and resins able to complex heavy metals; human serum albumin as lyophilization protection agent and sugars as stabilizers |
| 09/14/1993 | CA2091534A1 Method and composition for the treatment of osteoporosis |
| 09/14/1993 | CA2091151A1 Retroviral protease inhibitors |
| 09/14/1993 | CA1322166C Process for the preparation of collagen and obtained product |
| 09/14/1993 | CA1322165C Method for treating iron overload |
| 09/14/1993 | CA1322164C Wound healing |
| 09/14/1993 | CA1322163C Plasminogen activator production |
| 09/14/1993 | CA1322161C Use of human blood coagulation factor xiii for the treatment of ulcerative colitis |
| 09/14/1993 | CA1322160C Therapeutic use of enkephalinase |
| 09/14/1993 | CA1322159C Animal growth promotant |
| 09/14/1993 | CA1322158C Uses of recombinant colony stimulating factor-1 |
| 09/14/1993 | CA1322157C Bifunctional proteins |
| 09/11/1993 | CA2091292A1 New derivatives of .beta.-amino acids |
| 09/09/1993 | DE4207254A1 4-oxo-2-thioxoimidazolidin-derivate 4-oxo-2-thioxoimidazolidin-derivatives |
| 09/08/1993 | EP0559632A2 Method of producing tissue factor pathway inhibitor |
| 09/08/1993 | EP0559428A2 Novel polypeptides and DNAs encoding them |
| 09/08/1993 | EP0559425A1 Formulated medicine for treatment and/or prevention of opportunistic infectious diseases complicated by infection with lentivirus |
| 09/08/1993 | EP0559234A1 Monoclonal antibodies specific for an epitope in the B chain of platelet-derived growth factor and their use in affinity chromatography |
| 09/08/1993 | EP0559145A1 Therapeutic agent for threatened abortion |
| 09/08/1993 | EP0559046A1 N-amidinopiperidinyl(3/4)- or N-amidino-1,4-Oxazinyl(2)-substituted sulfonamides, process for their preparation and use as thrombin inhibitors |
| 09/08/1993 | EP0558961A2 Glycopeptide derivatives, process for their manufacture and pharmaceutical compositions comprising them |
| 09/08/1993 | EP0558751A1 Therapeutic agent for skin or corneal disease |
| 09/08/1993 | EP0558727A1 Bone-growth-stimulating composition |
| 09/08/1993 | EP0558697A1 Localized oligonucleotide therapy |
| 09/08/1993 | EP0558681A1 Treatment for tissue ulceration |
| 09/08/1993 | EP0558671A1 Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures |
| 09/08/1993 | EP0558648A1 Improved matrix metalloprotease inhibitors |
| 09/08/1993 | EP0558645A1 Erythrocytes and thrombo-erythrocytes as target specific agents |
| 09/08/1993 | EP0558630A1 Retroviral protease inhibitors |
| 09/08/1993 | EP0558603A1 Retroviral protease inhibitors |
| 09/08/1993 | EP0558490A1 Portable ribozyme cassettes, dna sequences containing them, ribozymes encoded by these dna sequences, and compositions containing these ribozymes |
| 09/08/1993 | EP0505353B1 Fast printer with a particle trap in the paper channel |
| 09/08/1993 | EP0422156B1 New use of somatostatin |
| 09/08/1993 | CN1075988A 多元溶剂清洗系统 Multiple solvent cleaning system |
| 09/08/1993 | CN1075874A Medicine for treating atrophic gastritis |
| 09/07/1993 | US5243094 Derivatives of long chain fatty alcohols, their uses, particularly as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing them |